R I Wise. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Anti-Bacterial Agents/administration & dosageAnti-Bacterial Agents/therapeutic useCarbon Dioxide/metabolismCarbon IsotopesCephalosporins/therapeutic useCross Infection/epidemiologyEuropeHospitals, TeachingHumansIsraelPenicillin ResistancePenicillins/adverse effectsPenicillins/therapeutic useProtein BindingStaphylococcal Infections/diagnosisStaphylococcal Infections/drug therapyStaphylococcal Infections/epidemiologyStaphylococcal Infections/etiologyStaphylococcal Infections/microbiologyStaphylococcal Infections/therapyStaphylococcus/isolation & purificationStaphylococcus/metabolismTime FactorsUnited StatesVancomycin/administration & dosageVancomycin/therapeutic use
Substances： See more » Anti-Bacterial AgentsCarbon IsotopesCephalosporinsPenicillinsCarbon DioxideVancomycin
Year: 1973 PMID： 4578992 DOI： 10.1097/00005792-197307000-00008
Source DB: PubMed Journal: Medicine (Baltimore) ISSN： 0025-7974 Impact factor: 1.889